Home > News > Nanophase Technologies Corporation: Staying Small
July 16th, 2007
Nanophase Technologies Corporation: Staying Small
Abstract:
Analysts consider Nanophase's technology to be impressive even among nanotech companies. It has patents not just for the particles it produces, but for special processes such as coating the surfaces of the particles to make them stable in a wide variety of fluids, resins and polymers, prolonging their shelf-life. It can disperse its particles evenly in solution and keep them from sticking together for about 18 months before being used.
The question, however, is if these products can turn a profit - something that has eluded Nanophase and other nanotechnology companies for years. For the quarter ended March 31, its revenues were $2.9 million, up from $2.0 million a year earlier, with a net loss of $1.2 million, compared with a $1.5 million net loss a year ago. Its gross profit was $713,162, compared with $337,817 a year ago.
Source:
seekingalpha.com
Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Materials/Metamaterials/Magnetoresistance
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Focused ion beam technology: A single tool for a wide range of applications January 12th, 2024
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||